topiramate glp 1 GLP-1 anti-obesity medicines remain too expensive Compounded GLP-1 - Semaglutide &

New medicines that mimic a natural gut hormone called GLP-1 have already changed how clinicians treat type 2 diabetes, obesity and related cardiometabolic consequences

On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list for outsourcing facilities, finding no clinical need for large-scale compounding of those substances

Yesat least on average

This covers your medical history, current medications, weight loss goals, and any conditions that might affect GLP-1 eligibility

GLP-1 drops vs injections: what to expect from each delivery method Understanding the differences between injectable and oral peptide delivery helps set realistic expectations and makes it easier to evaluate whether drops are working at the level they should

This program may be a fit if you: Want light support with food noise or portion awareness